{"DataElement":{"publicId":"3653766","version":"1","preferredName":"Clinical Study Protocol Stratum Group Risk Factor Stratification Risk Group Stratification Code","preferredDefinition":"information relating to the process of classifying patients into strata as part of the randomization process of the action plan for a clinical trial by segregating them into groups based on a characteristic that increases the likelihood of a disease, condition or injury, which ultimately is used to assign study subjects to arms on a study._a numbered system for stratification based on risk factors and used for participation on a clinical study.","longName":"3653283v1.0:3653761v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"3653283","version":"1","preferredName":"Clinical Study Protocol Stratum Group Risk Factor Stratification","preferredDefinition":"information relating to the process of classifying patients into strata as part of the randomization process of the action plan for a clinical trial by segregating them into groups based on a characteristic that increases the likelihood of a disease, condition or injury, which ultimately is used to assign study subjects to arms on a study.","longName":"2223331v1.0:3653281v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"2223331","version":"1","preferredName":"Protocol","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"C25320","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B105A-B8AD-27F8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3653281","version":"1","preferredName":"Stratum Group Risk Factor Stratification","preferredDefinition":"A designation used to segregate study subjects into collections in order to balance the study for analysis. The stratum group is made up of a combination of stratification criterion answers, which ultimately is used to assign study subjects to arms on a study.:Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations.:The process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"C93397:C17103:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stratum Group","conceptCode":"C93397","definition":"A designation used to segregate study subjects into collections in order to balance the study for analysis. The stratum group is made up of a combination of stratification criterion answers, which ultimately is used to assign study subjects to arms on a study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk Factor","conceptCode":"C17103","definition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D38395F3-3B7B-66F3-E040-BB89AD4361FA","latestVersionIndicator":"Yes","beginDate":"2013-01-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-17","modifiedBy":"ONEDATA","dateModified":"2013-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D38395F3-3B8C-66F3-E040-BB89AD4361FA","latestVersionIndicator":"Yes","beginDate":"2013-01-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3653761","version":"1","preferredName":"Risk Group Stratification Code","preferredDefinition":"a numbered system for stratification based on risk factors and used for participation on a clinical study.","longName":"3653761v1.0","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Node-negative and RS > 25 treated with adjuvant chemotherapy","ValueMeaning":{"publicId":"3653762","version":"1","preferredName":"Node-negative and RS > 25 treated with adjuvant chemotherapy","longName":"3653762","preferredDefinition":"Node-negative and RS greater than 25 treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D396C642-1FF7-4382-E040-BB89AD435E8C","latestVersionIndicator":"Yes","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D396C642-2010-4382-E040-BB89AD435E8C","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"ONEDATA","dateModified":"2013-01-18","deletedIndicator":"No"},{"value":"2","valueDescription":"1-3 positive lymph nodes and RS > 25 treated with adjuvant chemotherapy","ValueMeaning":{"publicId":"3653763","version":"1","preferredName":"1-3 positive lymph nodes and RS > 25 treated with adjuvant chemotherapy","longName":"3653763","preferredDefinition":"1-3 positive lymph nodes and RS greater than 25 treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D396C642-201A-4382-E040-BB89AD435E8C","latestVersionIndicator":"Yes","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D396C642-2033-4382-E040-BB89AD435E8C","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"ONEDATA","dateModified":"2013-01-18","deletedIndicator":"No"},{"value":"3","valueDescription":">= 4 positive nodes (any RS value) treated with adjuvant chemotherapy","ValueMeaning":{"publicId":"3653764","version":"1","preferredName":">= 4 positive nodes (any RS value) treated with adjuvant chemotherapy","longName":"3653764","preferredDefinition":"Greater than or equal to 4 positive nodes of any RS value treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D396C642-203D-4382-E040-BB89AD435E8C","latestVersionIndicator":"Yes","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D396C642-2056-4382-E040-BB89AD435E8C","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"ONEDATA","dateModified":"2013-01-18","deletedIndicator":"No"},{"value":"4","valueDescription":">= 4 positive lymph nodes with neoadjuvant chemotherapy","ValueMeaning":{"publicId":"3653765","version":"1","preferredName":">= 4 positive lymph nodes with neoadjuvant chemotherapy","longName":"3653765","preferredDefinition":"Greater than or equal to 4 positive lymph nodes with neoadjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D396C642-2060-4382-E040-BB89AD435E8C","latestVersionIndicator":"Yes","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D396C642-2079-4382-E040-BB89AD435E8C","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"ONEDATA","dateModified":"2013-01-18","deletedIndicator":"No"},{"value":"4","valueDescription":">= 1 positive lymph node (any RS value) with neoadjuvant chemotherapy","ValueMeaning":{"publicId":"4701919","version":"1","preferredName":">= 1 positive lymph node (any RS value) with neoadjuvant chemotherapy","longName":"4701919","preferredDefinition":"Greater than or equal to 1 positive lymph node (any RS value) with neoadjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E4BD633-84B1-77AC-E050-BB89AD432AF5","latestVersionIndicator":"Yes","beginDate":"2015-02-04","endDate":null,"createdBy":"KEARNSD","dateCreated":"2015-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E4BD633-84CA-77AC-E050-BB89AD432AF5","beginDate":"2015-02-04","endDate":null,"createdBy":"KEARNSD","dateCreated":"2015-02-04","modifiedBy":"ONEDATA","dateModified":"2015-02-04","deletedIndicator":"No"},{"value":"2","valueDescription":"1-3 positive lymph nodes and RS > 25 or Grade III disease treated with adjuvant chemotherapy","ValueMeaning":{"publicId":"4701920","version":"1","preferredName":"1-3 positive lymph nodes and RS > 25 or Grade III disease treated with adjuvant chemotherapy","longName":"4701920","preferredDefinition":"1-3 positive lymph nodes and RS greater than 25 or Grade III disease treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E4BD633-84D4-77AC-E050-BB89AD432AF5","latestVersionIndicator":"Yes","beginDate":"2015-02-04","endDate":null,"createdBy":"KEARNSD","dateCreated":"2015-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E4BD633-84ED-77AC-E050-BB89AD432AF5","beginDate":"2015-02-04","endDate":null,"createdBy":"KEARNSD","dateCreated":"2015-02-04","modifiedBy":"ONEDATA","dateModified":"2015-02-04","deletedIndicator":"No"},{"value":"3","valueDescription":">= 4 positive lymph nodes (any RS value) treated with adjuvant chemotherapy","ValueMeaning":{"publicId":"4701921","version":"1","preferredName":">= 4 positive lymph nodes (any RS value) treated with adjuvant chemotherapy","longName":"4701921","preferredDefinition":"Greater than or equal to 4 positive lymph nodes of any RS value treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E4BD633-84F7-77AC-E050-BB89AD432AF5","latestVersionIndicator":"Yes","beginDate":"2015-02-04","endDate":null,"createdBy":"KEARNSD","dateCreated":"2015-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E4BD633-8510-77AC-E050-BB89AD432AF5","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2015-02-04","modifiedBy":"ONEDATA","dateModified":"2015-02-04","deletedIndicator":"No"},{"value":"1","valueDescription":"Node-negative and RS > 25 and tumor >= 2 cm treated with adjuvant chemotherapy","ValueMeaning":{"publicId":"5118493","version":"1","preferredName":"Node-negative and RS > 25 and tumor >= 2 cm treated with adjuvant chemotherapy","longName":"5118493","preferredDefinition":"Node-negative and RS greater than 25 treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE30882-644D-1CEB-E050-BB89AD436200","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE30882-6466-1CEB-E050-BB89AD436200","beginDate":"2013-01-18","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"2","valueDescription":"1-3 positive lymph nodes and RS > 25 or Grade III disease treated with adjuvant therapy","ValueMeaning":{"publicId":"5118494","version":"1","preferredName":"1-3 positive lymph nodes and RS > 25 or Grade III disease treated with adjuvant therapy","longName":"5118494","preferredDefinition":"1-3 positive lymph nodes and RS greater than 25 or Grade III disease treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE30882-6470-1CEB-E050-BB89AD436200","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE30882-6489-1CEB-E050-BB89AD436200","beginDate":"2015-02-04","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"3","valueDescription":">= 4 positive lymph nodes treated with adjuvant chemotherapy","ValueMeaning":{"publicId":"5118495","version":"1","preferredName":">= 4 positive lymph nodes treated with adjuvant chemotherapy","longName":"5118495","preferredDefinition":"Greater than or equal to 4 positive lymph nodes of any RS value treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE30882-6493-1CEB-E050-BB89AD436200","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE30882-64AC-1CEB-E050-BB89AD436200","beginDate":"2013-01-18","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"4","valueDescription":">= 1 positive lymph node with neoadjuvant chemotherapy","ValueMeaning":{"publicId":"5118496","version":"1","preferredName":">= 1 positive lymph node with neoadjuvant chemotherapy","longName":"5118496","preferredDefinition":"Greater than or equal to 1 positive lymph node (any RS value) with neoadjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AE30882-64B6-1CEB-E050-BB89AD436200","latestVersionIndicator":"Yes","beginDate":"2016-02-03","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2AE30882-64CF-1CEB-E050-BB89AD436200","beginDate":"2015-02-04","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-03","modifiedBy":"ONEDATA","dateModified":"2016-02-03","deletedIndicator":"No"},{"value":"1","valueDescription":"Node-negative and RS > 25 and tumor >= 2 cm treated with adjuvant therapy","ValueMeaning":{"publicId":"5122391","version":"1","preferredName":"Node-negative and RS > 25 and tumor >= 2 cm treated with adjuvant therapy","longName":"5122391","preferredDefinition":"Node-negative and RS greater than 25 treated with adjuvant therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B97134D-760C-4CF1-E050-BB89AD437297","latestVersionIndicator":"Yes","beginDate":"2016-02-12","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B97134D-7625-4CF1-E050-BB89AD437297","beginDate":"2013-01-18","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-12","modifiedBy":"ONEDATA","dateModified":"2016-02-12","deletedIndicator":"No"},{"value":"3","valueDescription":">= 4 positive lymph nodes treated with adjuvant therapy","ValueMeaning":{"publicId":"5122392","version":"1","preferredName":">= 4 positive lymph nodes treated with adjuvant therapy","longName":"5122392","preferredDefinition":"Greater than or equal to 4 positive lymph nodes of any RS value treated with adjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B97134D-762F-4CF1-E050-BB89AD437297","latestVersionIndicator":"Yes","beginDate":"2016-02-12","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B97134D-7648-4CF1-E050-BB89AD437297","beginDate":"2013-01-18","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-12","modifiedBy":"ONEDATA","dateModified":"2016-02-12","deletedIndicator":"No"},{"value":"4","valueDescription":">= 1 positive lymph node prior to or after neoadjuvant chemotherapy","ValueMeaning":{"publicId":"5122393","version":"1","preferredName":">= 1 positive lymph node prior to or after neoadjuvant chemotherapy","longName":"5122393","preferredDefinition":"Greater than or equal to 1 positive lymph node (any RS value) with neoadjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B97134D-7652-4CF1-E050-BB89AD437297","latestVersionIndicator":"Yes","beginDate":"2016-02-12","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B97134D-766B-4CF1-E050-BB89AD437297","beginDate":"2015-02-04","endDate":null,"createdBy":"NELSONA","dateCreated":"2016-02-12","modifiedBy":"ONEDATA","dateModified":"2016-02-12","deletedIndicator":"No"},{"value":"1","valueDescription":"Node-negative and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category in the primary tumor, and a tumor measuring ≥2 cm in greatest diameter treated with adjuvant therapy","ValueMeaning":{"publicId":"5915919","version":"1","preferredName":"Node-negative and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category in the primary tumor, and a tumor measuring ≥2 cm in greatest diameter treated with adjuvant therapy","longName":"5915919","preferredDefinition":"Node-negative and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category in the primary tumor, and a tumor measuring ≥2 cm in greatest diameter treated with adjuvant therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"553B86E5-CF0C-7055-E053-F662850A9699","latestVersionIndicator":"Yes","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"553B86E5-CF25-7055-E053-F662850A9699","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"ONEDATA","dateModified":"2017-07-26","deletedIndicator":"No"},{"value":"4","valueDescription":">= 1 positive lymph node after neoadjuvant chemotherapy","ValueMeaning":{"publicId":"5915928","version":"1","preferredName":">= 1 positive lymph node after neoadjuvant chemotherapy","longName":"5915928","preferredDefinition":">= 1 positive lymph node after neoadjuvant chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"553BC7D8-BDEF-5CC3-E053-F662850A3BFD","latestVersionIndicator":"Yes","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"553BC7D8-BE08-5CC3-E053-F662850A3BFD","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"ONEDATA","dateModified":"2017-07-26","deletedIndicator":"No"},{"value":"2","valueDescription":"1-3 positive lymph nodes and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category or Grade III disease treated with adjuvant therapy","ValueMeaning":{"publicId":"5915929","version":"1","preferredName":"1-3 positive lymph nodes and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category or Grade III disease treated with adjuvant therapy","longName":"5915929","preferredDefinition":"1-3 positive lymph nodes and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category or Grade III disease treated with adjuvant therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"553BC7D8-BE12-5CC3-E053-F662850A3BFD","latestVersionIndicator":"Yes","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"553BC7D8-BE2A-5CC3-E053-F662850A3BFD","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"ONEDATA","dateModified":"2017-07-26","deletedIndicator":"No"},{"value":"1","valueDescription":"Node-negative and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category in the primary tumor, and a tumor measuring >=2 cm in greatest diameter treated with adjuvant therapy","ValueMeaning":{"publicId":"5915930","version":"1","preferredName":"Node-negative and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category in the primary tumor, and a tumor measuring >=2 cm in greatest diameter treated with adjuvant therapy","longName":"5915930","preferredDefinition":"Node-negative and Oncotype DX® Recurrence Score >25 or a MammaPrint® assay in the high-risk category in the primary tumor, and a tumor measuring >=2 cm in greatest diameter treated with adjuvant therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"553BC7D8-BE34-5CC3-E053-F662850A3BFD","latestVersionIndicator":"Yes","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"553BC7D8-BE4D-5CC3-E053-F662850A3BFD","beginDate":"2017-07-26","endDate":null,"createdBy":"JOOSTENT","dateCreated":"2017-07-26","modifiedBy":"ONEDATA","dateModified":"2017-07-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D396C642-1FE1-4382-E040-BB89AD435E8C","latestVersionIndicator":"Yes","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"JOOSTENT","dateModified":"2017-07-26","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811961","version":"1","longName":"Protocol/Admin.","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Risk group","type":"Preferred Question Text","description":"Risk group","url":null,"context":"SWOG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D396C642-2083-4382-E040-BB89AD435E8C","latestVersionIndicator":"Yes","beginDate":"2013-01-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2013-01-18","modifiedBy":"JOOSTENT","dateModified":"2017-07-26","changeDescription":"Moved content from CTEP to SWOG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}